Dealing in securities by a director
AFROCENTRIC INVESTMENT CORPORATION LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT, ACTP
ISIN: ZAE000078416, ZAE000082269
(“AfroCentric” or “the Company”)
DIRECTORS DEALING ANNOUNCEMENT
In compliance with paragraphs 3.63 to 3.74 of the Listings
Requirements of the JSE Limited the following information is
disclosed:
Name of Director : A Meyer
Company : Chief Executive Officer of
Medscheme, a major subsidiary of
AfroCentric
Date of transaction : 18 November 2013
Nature of transaction : On market disposal
Class of security : Ordinary Shares
Number of securities : 2,986,983 ordinary shares
Trade price : R4.15
Value of transaction : R12,395,979.45
Nature of interest : Direct beneficial
Number of securities : 613,017 ordinary shares
Trade price : R4.10
Value of transaction : R2,513,369.70
Nature of interest : Direct beneficial
Clearance obtained : Yes
Trading prices on the
JSE for AfroCentric
on 18 November 2013:
High: 420 cents per share
Low: 410 cents per share
Johannesburg
20 November 2013
Sponsor
Sasfin Capital, a division of Sasfin Bank Limited
Date: 20/11/2013 08:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.